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1. Introduction
  Diabetes is a group of metabolic diseases characterized by 
hyperglycemia resulting from defects in insulin secretion, 
insulin action, or both. The total number of people with 
diabetes is projected to increase from 171 million in 2000 to 
366 million in 2030[1].
  The pathogenesis of diabetes mellitus is managed by 
insulin and oral administration of hypoglycemic drugs such 
as sulfonylureas and biguanides[2]. Unfortunately, apart from 
having a number of side effects, none of the oral synthetic 
hypoglycemic agents has been successful in diabetes 
management and controlling long-term microvascular 
and macrovascular complications[2-4]. The toxicity of oral 
antidiabetic agents differs widely in clinical manifestations, 
severity, and treatment[5].
  Alternative medicines particularly herbal medicines are 
available for the treatment of diabetes. Common advantages 
of herbal medicines are effectiveness, safety, affordability 
and acceptability[6]. Medicinal plants and their products 
have been used in the Indian traditional system of medicine 
and have shown experimental or clinical anti-diabetic 
activity[7,8]. Furthermore, World Health Organization has 
also recommended the evaluation of traditional plant 
treatments for diabetes[9].
  Dillenia indica (D. indica) plant belongs to family 
Dilleniaceae, commonly called Dillenia. The fruit shows 
laxative properties and is used for relieving abdominal 
pain. The bark and leaves have astringent effect[12]. The 
juice of D. indica leaves; bark and fruits are mixed and 
given orally for the treatment of cancer and diarrhea[13]. 
Fruits and leaves extracts of D. indica are reported to have 
antioxidant activity[14]. CNS depressant activities[15] and 
anti-inflammatory activity[16] in mice and antimicrobial 
activity[17] were found from the alcoholic extract of the 
leaves of D. indica. Traditionally, the plant is also used for 
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treatment of diabetes[18]. So, considering the traditional use 
this plant in diabetes treatment, this study was carried out 
in order to investigate the antidiabetic, hypolipidemic and 
histopathological analysis of D. indica methanolic leaves 
extract in alloxan induced diabetic rat.
2. Materials and methods
2.1. Plant material
  D. indica leaves were collected from the campus of 
Kurukshetra University, Kurukshetra, India during month of 
October, 2009 and were identified by Dr. HB Singh, scientist 
F & Head, Raw Material Herbarium & Museum, NISCAIR, 
and New Delhi, India. A voucher specimen of the plant is 
preserved in the herbarium (NISCAIR/RHMD/Consult/-2009-
10/1381/182/1).
2.2. Extract preparation
  The leaves were dried under shade and powdered to 
coarse particles. The powdered material were defatted with 
petroleum ether (60-80 曟) in Soxhlet extraction apparatus 
at 60 曟 and further the same amount material was extracted 
with methanol. The extract was dried at 45 曟 in rotary 
evaporator to produce a semisolid mass and stored in airtight 
containers in refrigerator below 10 曟.  
2.3. Chemicals
  Alloxan was purchased from Loba chemie Pvt. Ltd. 
Mumbai, India. Total cholesterol (TC), serum high-density 
lipoprotein (HDL), serum Creatinine (SC), serum urea (SU), 
serum alkaline phosphate (ALP), alanine transaminase 
(ALT), serum aspartate transaminase (AST)  and triglyceride 
(TG) standard kits were obtained from Erba diagnostics 
Mannheim Gambh, Germany. Blood glucose level was 
measured using Elegance glucose meter (CT-X10) of 
Convergent Technologies, Germany. All reagents used in 
study were analytical grade.
2.4. Animals
  Wistar rat of either sex, weighing about 150-250 g were 
used in the study. Animals were maintained under standard 
environmental conditions i.e. ambient temperature of (22 
依 2) 曟 and at 45%-55% relative humidity for 12 h, each 
of dark and light cycle and fed with a standard pellet rats 
diet obtained from Ashirwad Industries, Chandigarh, 
India and water was supplied ad libitum. All the studies 
were conducted in accordance with the Animal Ethical 
Committee of the University.
2.5. Induction of diabetes
  Rats were made diabetic by a single intraperitoneal 
injection of alloxan monohydrate (Loba Chemie, Bombay; 
150 mg/kg i.p.) in sterile saline. Twelve days after Alloxan 
injection, rats with blood glucose level of >200 mg/dL were 
separated and used for the study. Blood glucose levels were 
measured using blood glucose test strips with elegance 
glucometer (Frankenberg, Germany) at weekly intervals till 
the end of study (i.e. 3 weeks). Blood glucose estimation and 
body weight measurement were done on 0, 7, 14 and 21 day 
after administration of extract orally.
2.6. Experimental design
  Overnight fasted rats were divided into five groups and for 
each group six animals and treated orally once a day for 21 
days as follows:
Group I. Normal healthy control: given only vehicle (Tween 
80, 1% v/v)
Group II. Diabetic control: given only vehicle (Tween 80, 5% 
v/v)
Group III. Diabetic rats given DIME (250 mg/kg b.w.) 
Group IV. Diabetic rats given DIME (500 mg/kg b.w.)
Group V. Diabetic rats given glibenclamide (10 mg/kg b.w.).
2.7. Biochemical parameters
  Blood glucose was measured with elegance glucometer 
(Frankenberg, Germany) at weekly intervals i.e. 0, 7, 14 
and 21 day after daily administration of extract orally. 
After blood glucose estimation on day 21, whole blood was 
collected by cardiac puncture under mild ether anesthesia 
from rats. Serum cholesterol, triglycerides, creatinine, 
urea, alkaline phosphatase, HDL and total proteins levels 
were also evaluated in normal and alloxan induces diabetic 
rats[19]. Serum alanine transaminase (ALT) and serum 
aspartate transaminase (AST) were measured by autoanalyser 
(Erba Chem 7, Mannheim, Germany) using Erba diagnostic 
kits[20-21]. Serum insulin levels were determined using 
insulin ELISA kit[22].
2.8. Statistical analysis
  All values of results are presented as mean 依 standard 
error of mean (S.E.M.) The statistical analysis involving two 
groups was evaluated by means of Student’s t-test whereas 
one way analysis of variance (ANOVA) followed by Dunnet’s 
multiple comparison post-test was used for statistical 
comparison between control and various treated groups. 
Statistical significance was accepted at the P<0.05 values.
3. Results 
3.1. Antidiabetic activity
  Single dose alloxan monohydrate (150 mg/kg) significantly 
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(P<0.01) increases the blood glucose as shown in Table 1. 
After the daily oral administration with DIME (250 and 500 
mg/kg, p.o.), for 21 days, significant decreased (P<0.01) in 
the blood glucose levels was observed in the diabetic rats. 
The reduced insulin level in diabetic rats was also significantly 
improved by treatment of DIME. At the end of experiment (21st 
day) blood glucose level was (145.22 依 2.25)  mg/dL and
(123.23 依 2.41) mg/dL of the groups treated with the doses of 
DIME 250 and 500 mg/kg respectively (Table 1). 
3.2. Effect on body weight of rats
  In diabetic rats, continuous reduction in body weight was 
observed as shown in Table 2. Glibenclamide (10 mg/kg) 
as well as the extracts (DIME 250 and 500 mg/kg) treatment 
significantly (P<0.05) improved the body weight of diabetic 
rats.
3.3. Effect on lipid profile
  In diabetic rats, there was a significant increase of serum 
total cholesterol, triglycerides, and significant decrease 
in HDL cholesterol in compared to that of normal control. 
The standard drugs as well as DIME (250 and 500 mg/kg) 
plant extracts used in the experimental study significantly 
decreased (P<0.05) the levels of cholesterol and triglycerides 
whereas HDL cholesterol level was improved (Table 3) after 
21 days treatment.
3.4. Effect on liver functions
  The effect of DIME on liver functions is represented 
in the Table 3. ALT, AST, ALP and bilirubin levels were 
significantly elevated in alloxan induced diabetes. The rats 
treated with DIME (250 and 500 mg/kg) showed significant 
(P<0.01) reduction in the elevated levels of liver enzymes 
(transaminase) in a dose dependent manner. Bilirubin level 
was also decreased diabetic rats after DIME treatment. Total 
protein level was decreased significantly in diabetic rats and 
after 21 days DIME increased the level significantly (P<0.01) 
as shown in Table 4.
3.5. Effect on kidney functions
  Kidney function markers like creatinine and urea were 
elevated in the alloxan induced diabetic rats when compared 
with the normal rats. DIME reduced both the levels in dose 
dependent manner (Table 5). 
3.6. Histology of liver
  Photomicrographs of liver (Figure 1) showed normal 
hepatic cells with well preserved cytoplasm, nucleus, 
nucleolus and central vein (A).  In case of group II diabetic 
rats, the normal lobular structure was preserved. The central 
vein was prominent and prominently congested. Focal areas 
of hemorrhage were also seen. Fatty change was evident. 
The portal tracts appeared normal (B). In group IV [diabetic 
rats + DIME 500 mg/kg], the hepatocytes portal tracts and 
central veins appear normal (C). 
3.7. Histology of pancreas
  Histology of pancreas (Figure 2) showed normal acini, and 
normal cellular in the islets of langerhans in the pancreas 
of normal control (A).  In diabetic animals treated extensive 
damage to islets of langerhans and reduced dimensions 
of islets were observed in diabetic rats (B) which were 
restorated toward normal cellular population size of islets by 
DIME 500 mg/kg treatment (C).
3.8. Histology of kidney
  Histology of kidney (Figure 3) in normal animals showed 
normal structure (A). In diabetic rats, mild thickening of 
the basement membrane of the arterioles of glomeruli along 
with mild change of density of mesangial mesangium were 
observed. No other significant changes were seen (B). After 
DIME 500 mg/kg treatment, these changes were improved 
towards normal condition (C).
Figure 1. Effect of DIME 500 mg/kg on rat liver (A: Normal rats, B: Diabetic rats, C: A-D + 500 mg/kg).
A
B C
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Figure 3. Effect of DIME on rat kidney (A: Normal rats, B: Diabetic rats, C: A-D + 500 mg/kg).
Table 1
Effect of DIME on the blood glucose and insulin levels in alloxan diabetic rat (A-D)(n=6).
Groups/Treatments
Blood glucose level (mg/dL)
Serum insulin(IU/dL)
Initial day Day  7 Day 14 Day 21
I: Normal + Vehicle 115.27 依 4.50 113.34 依 3.80 112.70 依 5.20 113.82 依 2.40 4.30 依0.25 
II: A-D + vehicle 253.52 依 2.45 296.54 依 4.35 325.46 依 4.27 389.24 依 4.34 1.20 依2.50
III: A-D + DIME    (250 mg/kg) 252.21 依 2.24   234.20 依 2.25*   197.20 依 2.25* 145.22 依 2.25* 2.20 依1.24
IV: A-D + DIME (500 mg/kg) 265.52 依 2.70   226.43 依 2.90*   158.58 依 4.30* 123.23 依 2.41**   2.90 依2.48*
V: A-D + Glibenclamide(10 mg/kg. b.w.) 255.24 依 2.28 201.23 依 3.52     130.31 依 2.34** 116.42 依 2.80**   3.30 依1.87*
Data represent means 依 S.E.M. *P<0.05, **P<0.01, When groups III, IV and V compared with diabetic control i.e. group II, N= Numbers of 
animals in each group.
Table 2
Effect of DIME on the body weight in diabetic rats (n=6).
Groups/Treatments 
Body weight (g)
Initial day                                 Day 7                    Day 14 Day 21
I: Normal 215.20 依 2.35 222.43 依 4.22 225.41 依 3.62 228.47 依 3.17
II: A-D 224.34 依 2.70 220.21 依 2.42 212.25 依 1.52 207.13 依 2.48
III: A-D + DIME (250 mg/kg) 226.34 依 2.32 224.42 依 2.20* 225.44 依 3.42 227.23 依 2.35*
IV: A-D + DIME (500 mg/kg) 225.24 依 2.23 224.35 依 2.32 225.27 依 1.35* 226.23 依 1.43*
V: A-D + Std. (10 mg/kg. b.w.) 222.23 依 2.71 223.22 依 2.25* 225.53 依 2.59* 227.32 依 2.43*
Data represent means 依 S.E.M., *P<0.05, When groups III, IV and V compared with diabetic control i.e. group II.
 
Table 3
Effect of DIME on lipid profile (mg/dL) in alloxan induced diabetic rats.
Groups/Treatments Total cholesterol Triglycerides HDL cholesterol
I: Normal   87.28 依 3.80   82.42 依 5.16 37.32 依 2.90
II: A-D 254.73 依 7.60 150.52 依 4.71 28.23 依 2.20
III: A-D + DIME (250 mg/kg) 125.32 依 11.20* 117.24 依 4.51* 34.24 依 3.50*
IV: A-D + DIME (500 mg/kg) 110.47 依 4.70*   92.24 依 6.32** 41.35 依 2.60*
V: A-D + Std (10 mg/kg. b.w.)   98.72 依 5.30*   83.47 依 4.50* 45.28 依 4.80**
Data represent means 依 S.E.M. *P<0.05, **P<0.01.
Figure 2. Effect of DIME on rat pancreas (A: Normal rats, B: Diabetic rats, C: A-D + 500 mg/kg).
A B
C
A B C
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4. Discussion
  Alloxan acts as diabetogenic by the destruction of 毬-cells 
of the islets of langerhans and causes massive reduction in 
insulin release, thereby inducing hyperglycaemia[23] Insulin 
deficiency leads to various metabolic alterations in the 
animals viz increased blood glucose, increased cholesterol, 
increased levels of alkaline phosphate and transaminases 
etc[24-25]. Single dose intra-peritoneal (i.p) treatment of rats 
with alloxan monohydrate (150 mg/kg) significantly (P<0.01) 
increases the blood glucose as shown in Table 1. DIME and 
glibenclamide were found to reduce the elevated glucose 
level significantly in alloxan induced diabetes animals 
during 21 days treatment. The DIME treatment has also 
increased the insulin level. So, one possible antidiabetic 
mechanism of D. indica extract may be stimulation of 
insulin secretion. A significant weight loss was observed in 
the diabetic group which was improved significantly by the 
DIME treated groups as urinary glucose and peotein release 
was restored after treatment.
  The most common lipid abnormalities in diabetes are 
hypertriglyceridemia and hypercholesterolemia[26]. Repeated 
administration of the DIME for 21 days significantly (P<0.05) 
decreased hypertriglyceridemia and hypercholesterolemia, 
the observed hypolipidemic effect may be due to decreased 
cholesterologenesis and fatty acid synthesis[27-37]. HDL 
cholesterol level was significantly improved by the extract.
  Liver enzymes e.g. AST, ALT and ALP level were increased 
in diabetic rats which is responsible for the liver damage. 
The elevated serum level of these enzymes was significantly 
reduced by DIME treatment. The diabetic complications 
such as increased gluconeogenesis and ketogenesis may be 
due to elevated enzymes[38]. The restoration of transaminases 
to their normal levels also treatment also indicates revival of 
insulin secretion.
  DIME also improved renal functions in diabetic rats by 
reducing serum urea and creatinine. So, DIME normalizes 
the functions of vital organs of rats. Alloxan has been shown 
to induce free radical production and cause tissue injury. 
Histopatholigical studies of tissues of organs (liver, pancreas 
and kidney were undertaken and it was found that DIME was 
non-toxic and regenerated the toxic effect of alloxan.
  The pancreas is especially susceptible to the action of 
alloxan induced free radical damage. D. indica leaves are 
rich in polyphenols and have in vitro antioxidant effect[39]. 
So, antioxidant potential of the plant has protective effect on 
the organ. Also, various studies have shown that diabetes 
is associated with increased formation of free radicals and 
decrease in antioxidant potential.
  The result of the present study showed that DIME brings 
back the blood glucose and body weight to normal in 
diabetes-induced rats. It also improved kidney, liver 
function and hyperlipidaemia due to diabetes. After 
treatment with extract, liver section of diabetic rats 
hepatocytes, portal tracts and central veins appeared normal. 
DIME has favorable effect to inhibit the histopathological 
changes of the pancreas and kidney in alloxan induced 
diabetes. Antidiabetic action of the plant in diabetic rats 
may be possible through the insulinomimetic action or by 
other mechanism such as stimulation of glucose uptake 
by peripheral tissue, inhibition of endogenous glucose 
production, or activation of gluconeogenesis in liver 
and muscle. Although the exact chemical compounds 
responsible for the hypoglycemic effects of D. indica still 
remain speculative, experimental evidence obtained from 
this study indicates that D. indica possess antidiabetic 
property, which also is confirmed by histopathological 
examination.
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